Evaluation of Intervention on Impaired Glucose Tolerance(IGT) in Patients With Coronary Heart Disease.

Ministry of Science and Technology of the People´s Republic of China1,600 enrolled

Overview

The purpose of this study is to determine whether therapeutic intervention on impaired glucose tolerance in patients with coronary heart disease can decrease the incidence of new onset DM.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

TRIPLE

Enrollment

1,600

Conditions

Coronary Heart Disease Impaired Glucose Tolerance

Interventions

Voglibose tabletsDRUG

0.2mg Tid

Eligibility

Sex: ALLMin age: 40 YearsMax age: 75 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with coronary heart disease * Impaired Glucose Tolerance Exclusion Criteria: * Age \< 40yr or \> 75yr * Diabetes Mellitus * Scr \> 2.0 mg/dL（176 μmol/L） * ALT or AST \> 2.5 ULN * Hb \< 90g/L * Heart Failure * Infection * Undergo other interventional clinical trial

Locations (1)

Peking University First Hospital

Beijing, Beijing Municipality, China

RECRUITING

Outcomes

Primary Outcomes

TypeⅡDiabetes Mellitus

Time frame: 2 years

Secondary Outcomes

Occurrence of Cardiovascular Events

Time frame: 2 years

Central Contacts

Wenhui Ding, Professor

CONTACT

86-10-66551122 dwh_rd@126.com

Libin Shi

CONTACT

shlb1975@yahoo.com.cn

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.